Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease multiple endocrine neoplasia type 1
Comorbidity C0279628|esophageal adenocarcinoma
Sentences 2
PubMedID- 22759597 Tumor response to an s-1 regimen in patients with advanced esophageal adenocarcinoma, however, remains to be elucidated.
PubMedID- 21258083 Conclusion: 5-fluorodeoxyuridine, leucovorin, oxaliplatin and docetaxel regimen is active in patients with esophageal adenocarcinoma.

Page: 1